# ZBTB7B

## Overview
ZBTB7B is a gene that encodes the zinc finger and BTB domain-containing 7B protein, a transcription factor crucial for various biological processes, particularly in the immune system. This protein is characterized by its zinc finger motifs, which facilitate DNA binding, and a BTB domain, which is involved in protein-protein interactions, categorizing it as a transcription factor. ZBTB7B plays a pivotal role in T cell development and function, especially in maintaining the identity of CD4+ T cells by repressing CD8-lineage gene expression (Wang2008The). Beyond its immunological functions, ZBTB7B is implicated in the regulation of gene expression through interactions with histone deacetylases and acetyltransferases, influencing chromatin structure and transcriptional activity (Zhu2024ZBTB7B). Clinically, alterations in ZBTB7B expression are associated with diseases such as hepatocellular carcinoma and ulcerative colitis, highlighting its potential as a therapeutic target (Xu2022Epigenetic; Zhu2024ZBTB7B).

## Function
ZBTB7B, also known as Th-POK, is a zinc finger transcription factor that plays a critical role in the development and function of T cells, particularly in maintaining the identity of CD4+ T cells by repressing CD8-lineage gene expression. In healthy human cells, ZBTB7B prevents the inappropriate expression of CD8-lineage genes, including CD8 itself and cytotoxic effectors like perforin and Granzyme B, ensuring that CD4+ T cells do not adopt a cytotoxic CD8+ T cell phenotype (Wang2008The). This repression is essential for maintaining the distinct functional properties of CD4+ and CD8+ T cell lineages, and it is achieved potentially through direct binding to the CD8 locus or by promoting epigenetic silencing (Wang2008The).

ZBTB7B is also involved in the lineage commitment of T cells in the thymus, influencing whether thymocytes will become CD4+ or CD8+ T cells by repressing RUNX3, a factor that promotes CD8 expression (Cheng2021ZBTB). In mature CD4+ T cells, ZBTB7B is necessary for the differentiation of T follicular helper (Tfh) cells and the production of antigen-specific IgG, achieved by binding to regulatory regions of Bcl6 and Maf, promoting their expression (Cheng2021ZBTB).

## Clinical Significance
Alterations in the expression of the ZBTB7B gene have significant clinical implications, particularly in the context of liver cancer and ulcerative colitis (UC). In hepatocellular carcinoma (HCC), ZBTB7B acts as a tumor suppressor by repressing c-Jun expression and function. Its deficiency in hepatocytes accelerates liver cancer development, making the liver more susceptible to oncogene-induced hepatocarcinogenesis, especially through the Akt pathway. This deficiency leads to an increased presence of liver cancer gene signatures and proliferating hepatocytes, resulting in more tumors and a higher liver/body weight ratio in experimental models. Conversely, ectopic expression of ZBTB7B reduces tumor burden, highlighting its potential as a therapeutic target in liver cancer (Zhu2024ZBTB7B).

In ulcerative colitis, ZBTB7B, also known as ThPOK, is upregulated due to hypo-methylation, which correlates with increased disease activity. This upregulation is associated with the maturation of CD4+ T cells and the repression of double-positive CD4+CD8+ T cells, leading to the production of inflammatory cytokines such as TNF-α, IL-17, and IFN-γ. These cytokines contribute to the inflammatory environment characteristic of UC, suggesting that ZBTB7B could serve as a diagnostic and therapeutic biomarker for the disease (Xu2022Epigenetic).

## Interactions
ZBTB7B, a transcription factor, engages in various interactions with proteins and nucleic acids that influence its regulatory functions. In the context of hepatocellular carcinoma (HCC), ZBTB7B interacts with the c-Jun protein, acting as a negative regulator by repressing c-Jun expression and function. This interaction is crucial in inhibiting liver cancer initiation, as ZBTB7B competes with c-Jun for chromatin binding, thereby reducing c-Jun's tumor-promoting effects (Zhu2024ZBTB7B).

ZBTB7B also forms complexes with various transcriptional corepressors and epigenetic regulators. It interacts with class I and II histone deacetylases (HDACs), forming complexes with Sin3a and NcoR2, and with acetyltransferases like p300 and KAT5, indicating its role in histone acetylation and gene transcription regulation (Zhu2024ZBTB7B). Additionally, ZBTB7B interacts with proteins such as CBX3, CTBP1/2, UHRF1, and WDR5, highlighting its involvement in complex gene transcription modulation (Zhu2024ZBTB7B).

In the context of brown and beige fat development, ZBTB7B interacts with the long noncoding RNA Blnc1 through the nuclear RNA-binding protein hnRNPU. This interaction is essential for the activation of thermogenic gene programs, as ZBTB7B recruits the Blnc1/hnRNPU complex to stimulate genes involved in fuel oxidation and thermogenesis (Li2017Zbtb7b).


## References


[1. (Xu2022Epigenetic) Hao-ming Xu, Jing Xu, Mei-feng Yang, Yu-jie Liang, Quan-zhou Peng, Yuan Zhang, Cheng-mei Tian, Yu-qiang Nie, Li-sheng Wang, Jun Yao, and De-feng Li. Epigenetic dna methylation of zbtb7b regulates the population of double-positive cd4+cd8+ t cells in ulcerative colitis. Journal of Translational Medicine, June 2022. URL: http://dx.doi.org/10.1186/s12967-022-03477-6, doi:10.1186/s12967-022-03477-6. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-022-03477-6)

[2. (Wang2008The) Lie Wang, Kathryn F. Wildt, Ehydel Castro, Yumei Xiong, Lionel Feigenbaum, Lino Tessarollo, and Rémy Bosselut. The zinc finger transcription factor zbtb7b represses cd8-lineage gene expression in peripheral cd4+ t cells. Immunity, 29(6):876–887, December 2008. URL: http://dx.doi.org/10.1016/j.immuni.2008.09.019, doi:10.1016/j.immuni.2008.09.019. This article has 123 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.immuni.2008.09.019)

[3. (Li2017Zbtb7b) Siming Li, Lin Mi, Lei Yu, Qi Yu, Tongyu Liu, Guo-Xiao Wang, Xu-Yun Zhao, Jun Wu, and Jiandie D. Lin. Zbtb7b engages the long noncoding rna blnc1 to drive brown and beige fat development and thermogenesis. Proceedings of the National Academy of Sciences, August 2017. URL: http://dx.doi.org/10.1073/pnas.1703494114, doi:10.1073/pnas.1703494114. This article has 86 citations.](https://doi.org/10.1073/pnas.1703494114)

[4. (Zhu2024ZBTB7B) Yue Zhu, Qinqin Wang, Xinyu Xie, Cuihong Ma, Yuemei Qiao, Yu Zhang, Yanjun Wu, Yuan Gao, Jing Jiang, Xin Liu, Jianfeng Chen, Chen Li, and Gaoxiang Ge. Zbtb7b is a permissive regulator of hepatocellular carcinoma initiation by repressing c-jun expression and function. Cell Death &amp; Disease, January 2024. URL: http://dx.doi.org/10.1038/s41419-024-06441-y, doi:10.1038/s41419-024-06441-y. This article has 1 citations.](https://doi.org/10.1038/s41419-024-06441-y)

[5. (Cheng2021ZBTB) Zhong-Yan Cheng, Ting-Ting He, Xiao-Ming Gao, Ying Zhao, and Jun Wang. Zbtb transcription factors: key regulators of the development, differentiation and effector function of t cells. Frontiers in Immunology, July 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.713294, doi:10.3389/fimmu.2021.713294. This article has 51 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.713294)